Alain Kuyumjian

We advised the initial purchasers on the investment-grade debt and concurrent tender offer

We advised the underwriters on the IPO and Nasdaq listing

We advised the initial purchasers on the sustainability-linked notes

We advised the underwriters on the SPAC IPO and Nasdaq listing

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $72 million initial public offering by Biodesix, Inc. The common stock is listed on…

Davis Polk advised CureVac N.V. on its $245.3 million initial public offering of 15,333,332 of its common shares, which includes 1,999,999 common shares from the full exercise of the…

Davis Polk advised the sales agent in connection with an SEC-registered at-the-market offering by Applied Therapeutics, Inc. of shares of its common stock for up to a maximum offering…

Davis Polk advised the underwriters in connection with the SEC-registered offering of 3,152,712 shares of common stock of Applied Therapeutics, Inc., including 411,223 shares of common…

Davis Polk advised the placement agents in connection with a private placement of shares of common stock of Applied Therapeutics, Inc. The aggregate proceeds of the private placement…

Davis Polk advised Banco Santander, S.A. on its concurrent exchange offers in the United States and Mexico to acquire all of the equity of Banco Santander México, S.A., Institución de Banca…